Children and pregnant women are the two sub-populations I mentioned previously.
> Given that COVID-19 disease is far milder in the majority of children than in adults, the risk–benefit of a pediatric SARS-CoV-2 vaccine must be carefully weighed [0]
> The prognostic significance, long-term implications and mechanism of this myocardial injury needs to be studied further, especially as vaccination efforts are rolled out to younger children. [1]
> While the safety, immunogenicity, and efficacy data for the 4 authorized vaccines are reassuring so far, none of these vaccines has been systematically studied in pregnant and breastfeeding people [2]
> it is important to remain transparent about the lack of information, acknowledge concerns, and support those who decide to defer vaccination until more data are available [2]
[0] SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges (Feb 2021)
https://www.nature.com/articles/s41390-021-01402-z
[1] COVID-19 Vaccination-Associated Myocarditis in Adolescents (August 2021)
https://pediatrics.aappublications.org/content/pediatrics/ea...
[2] SARS-CoV-2 Vaccination During Pregnancy: A Complex Decision (April 2021)
https://academic.oup.com/ofid/article/8/5/ofab180/6220034